BRIEF-Ablynx achieves second milestone in immuno-oncology collaboration
* ABLYNX ACHIEVES SECOND MILESTONE IN IMMUNO-ONCOLOGY COLLABORATION WITH MERCK & CO. , INC., KENILWORTH, NEW JERSEY, USA
May 22 CHS Inc:
* Jay Debertin elected president and CEO of CHS Inc.
* Debertin succeeds Carl Casale Source text for Eikon: Further company coverage:
* Sanofi and Regeneron announce approval of Kevzara(®) (sarilumab) to treat adult patients with moderately to severely active rheumatoid arthritis in the European Union
TOKYO, June 27 Japanese auto parts maker Takata Corp apologised on Tuesday to victims of its faulty air bags linked to at least 16 deaths and 180 injuries around the world.